导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.11% | 757/1050 |
| 近一周 | -3.08% | 814/1104 |
| 近一月 | -6.67% | 797/1102 |
| 近一季 | -15.51% | 966/1092 |
| 近半年 | -2.74% | 535/1070 |
| 近一年 | -9.77% | 753/1018 |
| 近两年 | 44.63% | 546/926 |
| 近三年 | 20.30% | 498/833 |
| 成立以来 | -34.73% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.29% 874/1070 |
43.18% 253/1101 |
- - |
- - |
| 2025 | 48.04% 209/1065 |
3.90% 486/1014 |
3.79% 375/1038 |
44.71% 130/1050 |
-5.14% 710/1065 |
| 2024 | -12.44% 811/1011 |
-7.19% 658/960 |
-9.89% 864/983 |
18.29% 98/991 |
-11.49% 939/1011 |
| 2023 | -30.52% 812/952 |
-9.27% 847/880 |
-8.22% 701/895 |
-11.81% 673/915 |
-5.39% 551/952 |
| 2022 | -24.38% 474/867 |
-15.85% 301/773 |
5.49% 492/806 |
-19.01% 735/845 |
5.17% 194/867 |
| 2021 | -26.58% 540/740 |
-11.35% 512/580 |
13.02% 288/659 |
-13.36% 581/704 |
-15.43% 684/740 |
| 2020 | 43.81% 276/554 |
5.33% 71/419 |
26.61% 170/466 |
-3.27% 451/517 |
11.49% 311/554 |
| 2019 | 24.56% 316/410 |
26.44% 600/1146 |
-11.03% 1111/1228 |
7.57% 150/390 |
2.93% 373/410 |
| 2018 | -24.80% 142/349 |
- - |
-10.52% 511/990 |
-6.89% 560/1000 |
-2.56% 30/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 东吴双三角股票A VS. 东吴新产业精选股票A(580008) |